Skip to content
ppharmaranks
Menu
Class IOngoing

Mojo Max Fusion XXX recall

FDA recall D-0396-2026 · initiated Oct 8, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 11, 2026How we research

Mohamed Hagar recalled Mojo Max Fusion XXX in Oct 2025 — an FDA Class I recall (D-0396-2026) because Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).

Most serious — a reasonable probability that use will cause serious harm or death.

Why it was recalled

Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).

Sold unapproved, or found to contain something undeclared

The product should not have been on sale in this form — often a supplement found to contain a hidden prescription drug.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

ALL LOTS, exp 12/31/2027

Quantity recalled: 125 boxes

Details

Product
Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0
Recalling company
Mohamed Hagar
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S. Nationwide
Initiated
Oct 8, 2025
FDA report date
Mar 11, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Mojo Max Fusion XXX recalled?
Mohamed Hagar recalled Mojo Max Fusion XXX in Oct 2025 — an FDA Class I recall (D-0396-2026) because Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule). Most serious — a reasonable probability that use will cause serious harm or death.
Why was Mojo Max Fusion XXX recalled?
Per the FDA enforcement record, the reason for recall D-0396-2026 was: Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Is a recalled Mojo Max Fusion XXX dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. Most serious — a reasonable probability that use will cause serious harm or death. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Mojo Max Fusion XXX are affected?
Distributed: U.S. Nationwide. The recall covers these lots — ALL LOTS, exp 12/31/2027. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0396-2026.

Source: openFDA Drug Enforcement record D-0396-2026

← All drug recalls